Dr Caleb Alexander examines the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.
Arguments are examined for and against the ethics of allowing U.S. armed services to attempt to recruit financially vulnerable students on medical school campuses.